Home
Pharmaceuticals
Licensing income can bring upsides to our target of $1B revenue by 2018: Kiran Mazumdar-Shaw of Biocon

Licensing income can bring upsides to our target of $1B revenue by 2018: Kiran Mazumdar-Shaw of Biocon

07 May 2014

Premium

Licensing income can bring upsides to our target of $1B revenue by 2018: Kiran Mazumdar-Shaw of Biocon

Biocon Ltd is India’s largest biotechnology company founded by Kiran Mazumdar-Shaw in 1978. The company, which started with an initial investment of Rs 10,000, reported revenue of Rs 2,933 crore (just around $500 million) and profit after tax (PAT) of Rs 414 crore for the year ended March 31, 2014. ......